Xi-Chun Hu

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Xi-Chun Hu, Jian Zhang, Bing-He Xu et al. · The Lancet Oncology · 2015 · 279 citations

First-line Therapy, Breast Oncology, Oncology +7

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

Bi-Yun Wang, Jian Zhang, Jia-Lei Wang et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 177 citations · Full text

Primary non-Hodgkin’s lymphoma of the breast: eight-year follow-up experience

Hai-Yi Guo, Xin-Min Zhao, Jin Li et al. · International Journal of Hematology · 2008 · 45 citations

Lymphoid Neoplasia, Breast Oncology, Medicine +4

The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer

Jian Zhang, Joseph Ragaz, Ying-Jian Zhang et al. · BMC Cancer · 2013 · 32 citations · Full text

Safety and efficacy of nimotuzumab in combination with radiotherapy for patients with squamous cell carcinoma of the esophagus

Ning-Yi Ma, Xu-Wei Cai, Xiaolong Fu et al. · International Journal of Clinical Oncology · 2013 · 30 citations

Esophageal Cancer, Radiation Therapy, Squamous Cell Carcinoma +6